Mirna Therapeutics Gains $1.5M In Equity Funding

Mirna Therapeutics, Inc. will be looking into further research and product development with the help of their most recent equity funding round worth $1.5 million.

They have also enjoyed  a couple of successful financing rounds from the Texas Emerging Technology Fund back in 2009 (worth $5 million) and in 2010 from the Cancer Prevention & Research Institute of Texas (CPRIT) (worth $10.3 million).

The company CEO Dr. Paul Lammers, MD, MSc has provided us more information about Mirna Therapeutics in this recent e-interview with Lead411:

Read More

Sangart Secures Series G Financing

Sangart has recently made known some great news. The company has acquired more than $50 million in Series G equity funding, giving them a total funding to date of over $230 million.

The most recent round was led by Leucadia National Corporation.

Their CEO Brian O’Callaghan shares some more information about the company in this recent e-interview with Lead411:

Read More